ctrl K

Watchlist Price Alert

InVivo Therapeutics Corp... (NVIV)

NASDAQ: NVIV · Real-Time Price · USD

0.32

-0.17 (-34.43%)

At close: Feb 12, 2024, 9:00 PM

InVivo Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	445K	372K	329K	322K	n/a	n/a	n/a
Gross Profit	-445K	-372K	-329K	-322K	n/a	n/a	n/a
Operating Income	-10.65M	-9.9M	-9.1M	-11.5M	-12.77M	-24.59M	-24.06M
Interest Income	151K	3K	19K	255K	n/a	189K	187K
Pretax Income	-10.49M	-9.89M	-9.07M	-11.83M	-23.42M	-26.75M	-23.44M
Net Income	-10.18M	-9.89M	-9.05M	-12.24M	-46.24M	-26.75M	-23.44M
Selling & General & Admin	5.42M	5.52M	5.16M	5.89M	7.84M	13.51M	11.51M
Research & Development	5.23M	4.38M	3.94M	5.6M	4.93M	11.08M	12.56M
Other Expenses	9K	2K	4K	79K	1.3M	n/a	n/a
Operating Expenses	10.65M	9.9M	9.1M	11.5M	12.77M	24.59M	24.06M
Interest Expense	151K	n/a	19K	254K	206K	74K	155K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	10.65M	9.9M	9.1M	11.5M	12.77M	24.59M	24.06M
Income Tax Expense	-311K	-3K	-19K	412K	22.82M	2.27M	-593K
Shares Outstanding (Basic)	1.54M	1.32M	276.11K	13.41K	6.65K	1.76K	1.65K
Shares Outstanding (Diluted)	1.54M	1.32M	276.11K	13.41K	6.65K	1.76K	1.65K
EPS (Basic)	-6.62	-7.47	-32.8	-912.63	-6.95K	-15.22K	-14.17K
EPS (Diluted)	-6.62	-7.47	-32.8	-912.63	-6.95K	-15.22K	-14.17K
EBITDA	-10.21M	-9.53M	-8.77M	-10.59M	-23.13M	-26.28M	-22.73M
EBIT	-10.34M	n/a	-9.05M	-11.58M	-23.22M	-26.67M	-23.28M
Depreciation & Amortization	445K	372K	329K	988K	12.26M	395K	553K